Avalo Therapeutics (AVTX) announced the appointment of Rita Jain, M.D. to its Board of Directors. Jain most recently served as Executive Vice President and Chief Medical Officer at ChemoCentryx
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX: